Caffeine/Propranolol Intervention for Acute Migraine
Completed · Phase 2 · Has a placebo group
Conditions studied: Migraine Disorders
In brief
This is a research study to assess the safety of caffeine/propranolol at different dose levels. We want to find out what effects, good and/or bad, it has on patients and their migraines.
Key facts
- Study ID
- NCT01080677
- Run by
- Stanford University
- People needed
- 60
- Starts
- 2007-01-01
- Expected to finish
- 2009-12-01
- Last updated by the study team
- 2017-02-24
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.